Non-invasive prenatal testing (NIPT) has transformed modern obstetric care by analyzing cell-free DNA from maternal plasma to identify fetal chromosomal abnormalities. Beyond detecting aneuploidies, sequencing data collected during routine screening contains non-human genetic fragments. Recent bioinformatics advancements demonstrate that these incidental sequences provide valuable insight into circulating maternal viral populations. A novel computational strategy simplifies NIPT viral read prediction, establishing an efficient pipeline that extracts maternal virome data without increasing sequencing costs.

Understanding Cell-Free DNA and the Maternal Virome

Cell-free fetal DNA originates primarily from apoptotic placental syncytiotrophoblasts, circulating alongside maternal nucleic acid fragments in blood plasma. Traditionally, bioinformaticians focus strictly on human chromosomal alignment to evaluate trisomies such as Down syndrome. However, maternal plasma samples also harbor circulating viral sequences, collectively termed the maternal virome. These genetic fragments stem from persistent latent viruses, subclinical infections, or commensal organisms residing within host tissues.

Consequently, analyzing non-human reads from existing prenatal datasets offers an opportunistic window into maternal viral dynamics. Standard computational tools discard unmapped reads or process them through exhaustive human genome alignment pipelines. While thorough, this conventional multi-step mapping requires heavy computational infrastructure and extended processing times. Furthermore, managing massive sequencing files places a financial strain on clinical diagnostic laboratories. By recognizing the secondary value of routine sequencing data, researchers are developing streamlined workflows to capture latent microbial information efficiently.

Comparing Bioinformatics Workflows in Genomic Screening

To extract non-human genetic signals efficiently, bioinformaticians compared two alignment workflows using cell-free DNA data from 888 Iranian pregnant participants. The conventional method uses a two-step mapping strategy. Reads align first to the human reference genome, and unmapped reads subsequently map against viral reference databases. Although accurate, aligning millions of raw reads against the massive human genome requires intensive computing power and extended processing hours.

In contrast, the proposed strategy aligns cell-free sequencing reads directly to viral reference genomes. By skipping primary human genome mapping, this direct workflow eliminates massive computational overhead. Crucially, comparative evaluations prove that direct mapping maintains analytical reproducibility comparable to conventional methodologies. Therefore, molecular genetics laboratories can achieve significant speed enhancements without sacrificing diagnostic accuracy. Moreover, faster bioinformatic processing enables high-throughput testing centers to complete viral profiling alongside routine fetal aneuploidy screening efficiently.

Optimizing NIPT Viral Read Prediction Efficiency

Reducing computational complexity is essential for integrating opportunistic pathogen screening into routine clinical practice. The streamlined pipeline for NIPT viral read prediction drastically reduces central processing unit hours, enabling rapid data interpretation on standard laboratory computing systems. In resource-constrained clinical settings, avoiding costly high-performance computing infrastructure lowers diagnostic overhead while accelerating turnaround times for patient reporting.

Furthermore, computational efficiency allows clinical geneticists to re-analyze historical prenatal datasets retrospectively without extra hardware investment. Because routine screening produces substantial sequencing data daily, lightweight direct alignment tools facilitate scalable population-wide virome studies. Consequently, diagnostic facilities can seamlessly integrate automated viral detection scripts into existing laboratory information systems without disrupting primary chromosomal analysis protocols. Additionally, simplified workflows minimize alignment artifacts, preserving low-abundance viral signals that aggressive human sequence filtering might otherwise remove.

Prevalence and Diversity of Detected Maternal Viral Sequences

Applying the simplified direct workflow across the cohort revealed putative viral nucleic acids in 24.2% of analyzed maternal plasma samples. The pipeline identified 29 distinct viral species, demonstrating notable diversity within the maternal virome. Frequently detected species included persistent human viruses such as anelloviruses, herpesviruses, and papillomaviruses, alongside various endemic viral entities circulating within the study population.

Notably, detecting these viral signatures confirms that circulating cell-free DNA reflects systemic viral host dynamics during pregnancy. Anelloviruses, for instance, represent common blood-borne viral elements whose circulating concentrations fluctuate according to host immune status. Detecting herpesvirus fragments similarly indicates subclinical viral activity that remains undetected during routine antenatal care. However, bioinformatic read identification from cell-free DNA does not confirm active infection or viral particle viability. These findings represent degraded viral nucleic acids released during cellular turnover.

Clinical Implications for Prenatal and Infectious Disease Management

Profiling circulating viral sequences during routine prenatal testing offers meaningful advantages for maternal-fetal healthcare. Congenital viral infections, including cytomegalovirus and herpes simplex virus, pose significant risks to fetal development, potentially causing birth defects or pregnancy complications. Early bioinformatic detection of viral nucleic acids can alert obstetricians to latent maternal infections before clinical symptoms appear, prompting appropriate diagnostic follow-up.

Furthermore, tracking maternal virome composition provides key insights into maternal immune adaptation during gestation. Normal pregnancy involves delicate immunological adjustments, and unexpected shifts in viral load may signal altered immune surveillance. However, translating computational viral detection into routine practice requires careful clinical interpretation. Clinicians must understand that bioinformatic predictions serve as preliminary screening markers rather than definitive clinical diagnoses. Therefore, secondary confirmatory testing remains mandatory before initiating clinical interventions.

Future Directions and Laboratory Validation Strategies

While in silico bioinformatic workflows provide valuable epidemiological data, rigorous experimental validation is required before clinical implementation. Future studies must validate predicted viral reads using targeted laboratory methodologies, such as quantitative polymerase chain reaction assays, serological testing, and viral isolation. These steps are critical to distinguish between active viral replication, integrated viral fragments, and transient environmental nucleic acids.

Additionally, prospective clinical studies are necessary to evaluate whether specific viral signatures correlate with adverse pregnancy outcomes. Establishing baseline viral reference values across different gestational trimesters will help clinicians differentiate normal viral shedding from pathological infections. Furthermore, testing diverse geographical populations will broaden understanding of environmental and genetic influences on maternal virome composition. Ultimately, combining simplified bioinformatic algorithms with strict validation protocols will advance non-invasive prenatal diagnostics.

Frequently Asked Questions

How does direct viral mapping differ from traditional NIPT bioinformatic pipelines?

Traditional NIPT pipelines first map cell-free DNA reads against the human genome and subsequently align unmapped sequences to viral databases. In contrast, direct mapping aligns reads directly to viral reference genomes, bypassing human genome alignment. This streamlined approach significantly reduces computational complexity, processing time, and server hardware requirements while maintaining comparable reproducibility and precision for identifying putative maternal viral sequences during routine non-invasive prenatal screening.

Does detecting viral reads in NIPT data indicate active clinical infection?

No, detecting viral genetic sequences through in silico bioinformatic prediction does not confirm an active, symptomatic viral infection or viable virion presence. Cell-free DNA fragments represent degraded nucleic acids released during cellular apoptosis or viral turnover. Therefore, positive bioinformatic reads must be interpreted as preliminary biological markers that require mandatory clinical correlation, validated serological testing, or confirmatory polymerase chain reaction assays before guiding clinical intervention.

What clinical benefits does maternal virome profiling offer in routine obstetric care?

Maternal virome profiling opportunisticly extracts valuable infectious disease data from existing non-invasive prenatal testing datasets without adding sample collection or sequencing costs. Identifying latent or subclinical viral sequences helps researchers monitor maternal immune adaptation and population-level viral prevalence. In the future, validated workflows may assist in identifying occult maternal infections early, enabling timely monitoring for vertical transmission risks and improving overall maternal-fetal health outcomes.

Disclaimer: This content is for informational and educational purposes only and should not be construed as medical advice. Healthcare professionals should exercise their independent clinical judgment when interpreting non-invasive prenatal testing results and diagnostic workflows. Refer to the latest local and national guidelines for clinical practice.

References

1. Shahidi S et al. A Simplified Workflow for the Prediction of Putative Viral Reads Using NIPT Data. Prenat Diagn. 2026 Aug 05. doi: 10.1002/pd.70233. PMID: 42555977.
2. Groot A et al. Distinct fragmentation patterns of circulating viral cell-free DNA in non-invasive prenatal testing samples. J Mol Diagn. 2022;24(5):476-484.
3. Sistermans EA et al. Screening the maternal virome with first trimester plasma cell-free DNA: challenges and clinical opportunities. Prenat Diagn. 2024;44(3):312-320.
Binding to local variable target count